Weed (BUDZ) Depreciation & Amortization (CF) (2010 - 2026)
Weed (BUDZ) posted quarterly Depreciation & Amortization (CF) of $5622.0 for Q1 2026, little changed year-over-year from $5622.0 in Q1 2025, and little changed quarter-over-quarter from $5622.0 in Q1 2025.
Weed (BUDZ) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Weed's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $5622.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $5622.0; the TTM figure through Mar 2026 stood at $5622.0 (changed 0.0% YoY), while the FY2025 annual figure was $22487.0, changed 0.44% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $5622.0, roughly flat from $5622.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $34949.0 in Q1 2022, with the low at $3711.0 in Q4 2023.
- The 5-year median for Depreciation & Amortization (CF) is $20143.0 (2023), against an average of $16060.3.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) grew 4.77% in 2022, then tumbled 83.98% in 2023.
- Weed's Depreciation & Amortization (CF) stood at $23163.0 in 2022, then sank by 83.98% to $3711.0 in 2023, then surged by 54.16% to $5721.0 in 2024, then dropped by 1.73% to $5622.0 in 2025, then changed by 0.0% to $5622.0 in 2026.
- Business Quant data shows BUDZ's Depreciation & Amortization (CF) at $5622.0 in Q1 2026, $5622.0 in Q1 2025, and $5721.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 5,435.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,622.00 |
| Mar 31, 2026 | 5,622.00 |
| Mar 31, 2025 | 5,622.00 |
| Mar 31, 2025 | 5,622.00 |
| Mar 31, 2024 | 5,721.00 |
| Mar 31, 2024 | 5,721.00 |
| Dec 31, 2023 | 3,711.00 |
| Dec 31, 2023 | 3,711.00 |
| Sep 30, 2023 | 5,120.00 |
| Sep 30, 2023 | 5,120.00 |
| Jun 30, 2023 | 20,143.00 |
| Jun 30, 2023 | 20,143.00 |
| Mar 31, 2023 | 24,030.00 |
| Mar 31, 2023 | 24,030.00 |
| Dec 31, 2022 | 23,163.00 |
| Dec 31, 2022 | 23,163.00 |
| Sep 30, 2022 | 20,605.00 |
| Sep 30, 2022 | 20,605.00 |
| Jun 30, 2022 | 27,977.00 |
| Jun 30, 2022 | 27,977.00 |